Azanucleosides, such as 5-azacytidine and decitabine, are DNA demethylating agents used in the treatment of acute myeloid leukemia myelodysplastic syndromes. Researchers continue to explore their utility other hematologic solid tumors. Based on capacity compounds inhibit methyltransferase enzymes important role methylation health disease, it is essential understand molecular changes that azanuc...